Cipla Unveils Generic Version of Oral Hepatitis C Drug in India

by Reshma Anand on  December 22, 2015 at 11:39 AM Corporate News
RSS Email Print This Page Comment
Font : A-A+

Indian drug maker, Cipla has announced that it has released the generic version of Hepatitis C drug, Sofosbuvir in India.

The drug will be marketed under the brand name 'Hepcvir-L' costing Rs 25,000 for a bottle of 28 tablets in India.
Cipla Unveils Generic Version of Oral Hepatitis C Drug in India
Cipla Unveils Generic Version of Oral Hepatitis C Drug in India

The company's product is a generic version of the drug maker Gilead Sciences Inc's Harvoni tablets. Gilead had decided to licence the manufacturing right of the medicine to generic companies to make it accessible in low-income countries soon after its launch in the US.

Hepcvir-L is the first once-a-day, fixed dose oral combination therapy that has been approved for chronic hepatitis C genotype 1 patients.

Managing Director and Global Chief Executive Officer Subhanu Saxena said, "The launch of Ledipasvir-Sofosbuvir is a further step to facilitate the optimal treatment for patients suffering from genotype 1 hepatitis C virus."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Hepatitis A Hepatitis B Vasculitis Signature Drug Toxicity Silent Killer Diseases Liver Aplastic Anemia Hepatitis C Dental Check-Up 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive